MVista® Histoplasma Antigen Quantitative EIA
Use
The MVista® Histoplasma Antigen Quantitative EIA test is used for the detection and quantification of the Histoplasma antigen in patients suspected of having histoplasmosis. This test aids in the diagnosis of histoplasmosis, a fungal infection that can affect individuals, especially those with weakened immune systems. It is valuable for both initial diagnosis and monitoring the effectiveness of treatment.
Special Instructions
This test is primarily used in individuals suspected of having histoplasmosis, and it can be useful in evaluating the response to antifungal therapy.
Limitations
The test may not detect the Histoplasma antigen in all infected patients, particularly those with localized infections. Cross-reactions with antigens from other fungi can occur, potentially leading to false-positive results. Clinical correlation and additional diagnostic methods may be necessary in some cases to confirm the diagnosis.
Methodology
Immunoassay (ELISA)
Biomarkers
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
5 mL
Container
Sterile container
Collection Instructions
Collect urine in a sterile container. No preservatives required.
Patient Preparation
No special preparation required.
Storage Instructions
Refrigerate if not processed within 2 hours.
Causes for Rejection
Specimens with preservatives, insufficient volume.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 72 hours |
| Frozen | 7 days |